Eitan Halper-Stromberg, MD, PhD

Pathology and Laboratory Medicine
Accepting new patients
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
Call 800-789-7366
Headshot of Eitan Halper-Stromberg, MD, PhD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Pathology and Laboratory Medicine

My education and training

  • Medical School: University of Colorado at Denver
  • Residency: Johns Hopkins Hospital
  • Fellowship: Johns Hopkins Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Halper-Stromberg is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Elghawy O, Stylli J, Kurian M, Halper-Stromberg E, Singh A, D'Avella C, Hartner L, Cohen RB. Clinicogenomic Features and Outcomes of Adenoid Cystic Carcinoma With Central Nervous System Metastases: A Single-Institution Cohort Study , Head Neck: 2026

Teh SSK, Kotwal A, Bennett A, Halper-Stromberg E, Morsberger L, Zamani S, Shi Y, Skaist A, Zhu Q, Bowland K, Liang H, Hruban RH, Hung CF, Anders RA, Roberts NJ, Scharpf RB, Goldstein M, Zou YS, Eshleman JR. Simultaneous CRISPR/Cas9-induced double-strand breaks are lethal in models of pancreatic cancer , J Clin Invest, 136: 2026,e190121

Ramesh R, Colbourn R, Van Deerlin VM, Halper-Stromberg E. T-cell receptor gamma (TRG) diversity predicts peripheral blood involvement in primary cutaneous T-cell lymphoma , Blood Neoplasia, 3: 2026,100204

Ling-Lin Pai E, Halper-Stromberg E, Herzog C, Odintsov I, Baranov E. Ultramutated Colonic Adenocarcinoma With Mismatch Repair Deficiency and Distinctive Mutational Signature Following Solid Organ Transplantation , Mod Pathol: 2026

Armstrong GZ, Dehner CA, Halper-Stromberg E, Baranov E, Eden AC, Kowal RP. Acral Mesenchymal Spindle Cell Neoplasm With a Novel HMGA2::NCOA2 Fusion , J Cutan Pathol: 2025

Eric C. Honaker, Laura M. Warmke, Ameline Baptiste, Daniel Baumhoer, Esther Baranov, Eitan Halper-Stromberg, Carina A. Dehner CD34-Positive Acral Chondromyxoid Mesenchymal Neoplasm Harboring a Novel TCF4::ERG Fusion , Genes, Chromosomes and Cancer, 64(8): 2025

Cappadocia J, Maxwell KN, Nathanson KL, Bagley S, Powers J, Halper-Stromberg E, Roth JJ, Domchek S, Shah PD. Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort , J Med Genet: 2025

Mawalkar, Resham; Tsai, Hua-Ling; Jouaneh, Terra Marie M; Patel, Shivam; Gocke, Christopher; Halper-Stromberg, Eitan; Xian, Rena R; Rappazzo, K C; Braunstein, Evan M; Moliterno, Alison R; Jain, Tania igh Molecular Risk Mutations (HMR) Drive Progression of CALR -Mutated Myeloproliferative Neoplasm (MPN) , Blood, 144(Supplement 1): 2024,3173

Kalghatgi, T., Von Reusner, J. Halper-Stromberg, E Evaluating Performance of LLMs for Generating Information That Would Appear on a Molecular Pathology Report and Genetic Variant Classification in Molecular Pathology , Journal of Molecular Diagnostics, 26(11): 2024,S73-S74

R Ramesh, R Colbourn, V Van Deerlin, E Halper-Stromberg Measuring T Cell Diversity Alongside Clonality May Prove Clinically Useful for Patients Undergoing NGS-Based T Cell Receptor Gamma Gene (TRG) Rearrangement Testing , Journal of Molecular Diagnostics, 26(11): 2024,S37-S37